10x Genomics, Inc. Financial Ratios — TXG Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-112.53	-8.56	-70.7	-5.98	-16.21	-25.59	-19.39	-4.44
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	85.14	80.41	75.18	80.44	84.89	76.69	66.15	67.86	69.05
EBITDA Margin (%)	-19.79	-9.51	-8.95	-22.19	-5.03	-26.13	-25.98	-24.7	-10.43
Operating Margin (%)	-25.85	-12.18	-11.82	-28.55	-10.79	-32.52	-33.03	-31.85	-17.25
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-26.36	-76.82	-12.62	-178.85	-10.95	-31.36	-40.21	-29.09	-6.21
Profit Margin (%)	-26.39	-76.88	-12.71	-181.61	-11.87	-32.15	-41.23	-29.9	-6.77
Net Income to Common Margin (%)	-26.39	-76.88	-12.71	-181.61	-11.87	-32.15	-41.23	-29.9	-6.77
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	11	30	30	63	82	95	95	83	84
ST Debt	4	4	10	6	5	9	12	9	11
LT Debt	6	25	20	57	77	86	84	73	73
Total Debt/EBITDA	-0.75	-2.13	-1.35	-0.95	-3.32	-0.71	-0.59	-0.55	-1.26
Net Debt/EBITDA	2.65	2.54	17.93	10.01	23.82	1.63	2.24	2.28	7.07
Total Debt/EBIT	-0.57	-1.67	-1.02	-0.74	-1.55	-0.57	-0.47	-0.42	-0.76
Net Debt/EBIT	2.03	1.99	13.57	7.78	11.1	1.31	1.76	1.77	4.27
EBITDA to Interest Expense	-17.35	-5.78	-7.15	-39.42	-28.47	-283.48	-4,870.61	-37,712.75	- -
EBITDA-CapEx/Interest Expense	-21.98	-8.56	-21.04	-62.25	-145.42	-560.08	-6,371.33	-41,061	- -
EBIT to Interest Expense	-22.66	-7.4	-9.44	-50.73	-61.1	-352.82	-6,192.39	-48,639.75	- -
Interest Expense	1	2	3	2	1	- -	- -	- -	- -
Common Equity/Total Assets	-156.9	-185.92	-43.3	-86.63	-84.74	-100.03	-133.08	-159.7	-145.06
Long-Term Debt/Equity (%)	- -	- -	4.72	7.72	9.4	10.69	11.31	10.33	9.21
Long-Term Debt/Capital (%)	-5.86	-12.65	-8.53	-7.69	-9.84	-9.22	-7.05	-5.3	-5.14
Long-Term Debt/Total Assets (%)	8.38	20.5	3.27	6.14	7.54	8.37	8.69	7.98	7.05
Total Debt/Equity (%)	-9.39	-13.49	7.07	8.52	10.03	11.81	12.87	11.63	10.59
Total Debt/Capital (%)	-9.77	-14.73	-12.77	-8.49	-10.49	-10.19	-8.02	-5.97	-5.91
Total Debt/Total Assets (%)	13.97	23.87	4.9	6.78	8.05	9.25	9.88	8.99	8.1
Net Debt to Equity	33.15	16.09	-93.9	-89.79	-71.85	-27.27	-48.48	-48.45	-59.52
Net Debt/Capital (%)	23.92	13.28	60.05	47.21	42.92	19.04	23.2	19.91	24.94
EBITDA	-14	-14	-22	-66	-25	-135	-161	-151	-67
EBITDA-CapEx	-18	-21	-65	-105	-126	-267	-210	-164	-73
Operating Income (Loss)	-18	-18	-29	-85	-53	-168	-204	-195	-111

Liquidity (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.16	2.01	6.73	5.62	5.32	3.28	3.06	3.34	3.41
Current Ratio	3.08	3.28	7.63	6.56	6.77	4.85	4.69	4.97	4.46
Quick Ratio	2.76	2.88	7.26	6.05	6.1	4.08	3.96	4.1	3.95
CFO/Avg Current Liab	- -	-2.8	0.73	-2.41	-0.19	-0.28	-0.12	0.05	1
Common Equity/Total Assets	-156.9	-185.92	-43.3	-86.63	-84.74	-100.03	-133.08	-159.7	-145.06
Long-Term Debt/Equity (%)	- -	- -	4.72	7.72	9.4	10.69	11.31	10.33	9.21
Long-Term Debt/Capital (%)	-5.86	-12.65	-8.53	-7.69	-9.84	-9.22	-7.05	-5.3	-5.14
Long-Term Debt/Total Assets (%)	8.38	20.5	3.27	6.14	7.54	8.37	8.69	7.98	7.05
Total Debt/Equity (%)	-9.39	-13.49	7.07	8.52	10.03	11.81	12.87	11.63	10.59
Total Debt/Capital (%)	-9.77	-14.73	-12.77	-8.49	-10.49	-10.19	-8.02	-5.97	-5.91
Total Debt/Total Assets (%)	13.97	23.87	4.9	6.78	8.05	9.25	9.88	8.99	8.1
CFO/Total Liabilities	-5.69	-22.19	18.63	-114.52	-10.62	-15.05	-6.78	3.2	55.52
CFO/CapEx	-2.85	-11.39	0.81	-5.68	-0.21	-0.26	-0.31	0.5	22.92
Altman's Z-Score	-1.33	-1.19	10.11	44.81	48.87	10.28	16.19	3.28	3.75

Working Capital (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	7.06	8	7.07	7.19	5.45	5.65	6.03	9.53
Days Sales Outstanding	- -	51.68	45.61	51.65	50.77	66.96	64.61	60.56	38.29
Inventory Turnover	- -	4.28	5.12	2.59	1.65	1.7	2.7	2.5	2.85
Days Inventory Outstanding	- -	85.38	71.29	141.18	221.5	214.65	135.37	145.79	127.92
Accounts Payable Turnover	- -	4.55	6.21	8.25	9.44	7.29	10.79	14.36	13.43
Accounts Payable Turnover Days	- -	80.2	58.79	44.25	38.67	50.04	33.82	25.42	27.18
Cash Conversion Cycle	- -	56.85	58.11	148.58	233.6	231.57	166.16	180.94	139.04
Inventory to Cash Days	- -	-33.7	-25.67	-89.53	-170.73	-147.69	-70.76	-85.22	-89.63
Inventories	5	9	15	30	60	82	74	83	56
Raw Materials	2	3	6	10	32	34	34	39	16
Work In Process	2	3	4	9	14	25	22	27	17
Finished Goods	1	3	5	11	14	22	17	17	23
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	2,981	14,323	16,437	4,149	6,557	1,730	2,035
- Cash & Cash Equivalents	48	65	424	664	587	220	359	344	474
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	11	30	30	63	82	95	95	83	84
Enterprise Value	-37	-35	2,586	13,722	15,932	3,814	6,263	1,419	1,596
Total Capital	-108	-201	-233	-742	-781	-934	-1,189	-1,384	-1,426
Total Debt/Capital (%)	-9.77	-14.73	-12.77	-8.49	-10.49	-10.19	-8.02	-5.97	-5.91
Total Debt / EV	-0.28	-0.84	0.01	- -	0.01	0.02	0.02	0.06	0.05
EV/Sales	- -	- -	10.52	45.92	32.48	7.39	10.12	2.32	2.48
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	68.55	- -	- -	- -	- -	212.79	11.73
EV/Free Cash Flow to Firm	- -	- -	32.13	- -	197.07	38.71	182.28	70.73	11.24
Diluted Market Cap	- -	- -	2,981	14,323	16,437	4,149	6,557	1,730	2,035
Diluted Enterprise Value	-37	-35	2,586	13,722	15,932	4,024	6,293	1,468	1,645
EV per Share	- -	- -	66.16	135.66	144.38	33.5	53.46	11.78	12.79
TTM Sales	71	146	246	299	490	516	619	611	643
TTM EBITDA	-14	-14	-22	-66	-25	-135	-161	-151	-67
TTM Operating Income	-18	-18	-29	-85	-53	-168	-204	-195	-111
TTM Cash Flow to Firm	-10	-74	38	-216	-20	-33	-15	7	136
TTM Free Cash Flow to Firm	-6	-67	80	-178	81	99	34	20	142

Multiples (USD)

MCP API Chat

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	38.51	-79.79	205.71	42.31	191	86.24	14.33
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-37	-35	2,586	13,722	15,932	3,814	6,263	1,419	1,596
Low Price	- -	- -	45.11	48.78	128.15	23.81	33.79	12.95	6.78
EV/Sales	- -	- -	10.52	45.92	32.48	7.39	10.12	2.32	2.48
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-74.19	-18.97	-321.34	-35.9	-22.54	-17.44	-35.79
Price/Earnings High	- -	- -	-111.3	-31	-396.09	-102.88	-29.2	-36.91	-58.27
Price/Earnings Low	- -	- -	-56.43	-9.09	-242.88	-16.33	-15.52	-8.54	-19.42
Price/Book Value	- -	- -	-11.36	-17.79	-19.04	-4.03	-5.1	-1.18	-1.35
Price/Book Value Average	- -	- -	-8.84	-12.79	-21.67	-5.79	-4.48	-2.17	-1.03
Price/Book Value High	- -	- -	-13.26	-20.9	-26.71	-16.59	-5.8	-4.59	-1.68
Price/Book Value Low	- -	- -	-6.72	-6.13	-16.38	-2.63	-3.08	-1.06	-0.56
Price/Tangible Book Value	- -	- -	7.49	19.98	20.87	5.33	9.11	2.51	2.79
Price/Tangible Book Value Average	- -	- -	5.83	14.36	23.75	7.66	7.99	4.62	2.14
Price/Tangible Book Value High	- -	- -	8.75	23.47	29.28	21.94	10.35	9.77	3.48
Price/Tangible Book Value Low	- -	- -	4.43	6.88	17.95	3.48	5.5	2.26	1.16
Price/Sales	- -	- -	12.12	47.93	33.51	8.03	10.6	2.83	3.17
Price/Sales Average	- -	- -	9.43	34.45	38.14	11.54	9.29	5.21	2.42
Price/Sales High	- -	- -	14.15	56.29	47.02	33.07	12.04	11.04	3.95
Price/Sales Low	- -	- -	7.17	16.51	28.83	5.25	6.4	2.55	1.32
Price/Cash Flow	- -	- -	86.08	-65.73	-769.07	-123.46	-431.44	259.56	14.96
Price/Cash Flow Average	- -	- -	66.96	-47.25	-875.38	-177.35	-378.38	477.9	11.45
Price/Cash Flow High	- -	- -	100.45	-77.2	-1,079.01	-508.2	-490.11	1,011.47	18.65
Price/Cash Flow Low	- -	- -	50.93	-22.64	-661.63	-80.67	-260.51	234.07	6.22
Price/Free Cash Flow Average	- -	- -	29.96	-57.35	234.15	60.78	167.52	158.78	10.97
Price/Free Cash Flow High	- -	- -	44.94	-93.72	288.61	174.17	216.98	336.07	17.87
Price/Free Cash Flow Low	- -	- -	22.78	-27.49	176.97	27.65	115.33	77.77	5.96
EV/Sales Average	- -	- -	7.83	32.44	37.11	11.3	8.87	4.79	1.82
EV/Sales High	- -	- -	12.54	54.28	45.99	32.83	11.61	10.61	3.34
EV/Sales Low	- -	- -	5.57	14.5	27.8	5.01	5.97	2.13	0.71
EV/EBITDA Average	2.65	2.54	-87.44	-146.22	-738.23	-43.24	-34.13	-19.38	-17.42
EV/EBITDA High	2.65	2.54	-140.15	-244.66	-914.72	-125.64	-44.7	-42.95	-32.02
EV/EBITDA Low	2.65	2.54	-62.21	-65.36	-552.97	-19.17	-22.99	-8.61	-6.8
EV/EBIT Average	2.03	1.99	-66.19	-113.62	-344.04	-34.75	-26.85	-15.03	-10.54
EV/EBIT High	2.03	1.99	-106.08	-190.12	-426.29	-100.95	-35.16	-33.3	-19.37
EV/EBIT Low	2.03	1.99	-47.09	-50.79	-257.7	-15.4	-18.08	-6.67	-4.11
Last Price	- -	- -	76.25	141.6	148.96	36.44	55.96	14.36	16.31
High Price	- -	- -	88.98	166.31	208.99	150	63.57	55.96	20.34
Enterprise Value Average	-37	-35	1,924	9,695	18,204	5,835	5,486	2,923	1,169
Enterprise Value High	-37	-35	3,084	16,222	22,556	16,954	7,184	6,479	2,148
Enterprise Value Low	-37	-35	1,369	4,334	13,636	2,586	3,695	1,298	456

Shares Outstanding	93	93	96	108	113	115	119	122	128
Diluted Weighted Avg Shares	83	83	39	101	110	114	117	120	125
Basic Weighted Avg Shares	83	83	39	101	110	114	117	120	125
Revenue per Share	0.86	1.77	6.29	2.95	4.44	4.54	5.28	5.07	5.15
EBITDA per Share	-0.17	-0.17	-0.56	-0.66	-0.22	-1.19	-1.37	-1.25	-0.54
Operating Income per Share	-0.22	-0.21	-0.74	-0.84	-0.48	-1.48	-1.74	-1.62	-0.89
Basic EPS, GAAP	-0.23	-1.36	-0.8	-5.37	-0.53	-1.46	-2.18	-1.52	-0.35
Basic EPS from Cont Ops	-0.23	-1.36	-0.8	-5.37	-0.53	-1.46	-2.18	-1.52	-0.35
Diluted EPS, GAAP	-0.23	-1.36	-0.8	-5.37	-0.53	-1.46	-2.18	-1.52	-0.35
Diluted EPS from Cont Ops	-0.23	-1.36	-0.8	-5.37	-0.53	-1.46	-2.18	-1.52	-0.35
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.13	-0.92	0.89	-2.15	-0.19	-0.3	-0.13	0.06	1.09
Free Cash Flow per Basic Share	-0.17	-1	-0.21	-2.53	-1.11	-1.45	-0.55	-0.06	1.04
Cash & Equivalents per Share	0.58	0.79	10.85	6.56	5.32	3.78	3.32	3.27	4.2
Book Value per Share	-1.43	-2.79	-6.71	-7.96	-7.82	-9.04	-10.96	-12.18	-12.11
Tangible Book Value per Share	-1.36	-2.65	10.17	7.09	7.14	6.84	6.14	5.73	5.85

10x Genomics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)